Next, the level of Nrf2 in the nucleus was measured, and our results revealed that GHK-Cu markedly increased its expression (Figures 4B,F)
1 Adverse reactions that occurred in 2% of patients treated with RADICAVA and 2% more frequently in placebo-treated patients 1 Hypersensitivity reactions and cases of anaphylaxis have been reported in postmarketing reports with RADICAVA 1 Discontinuations were not associated with contusion, gait disturbance, or headache in patients treated with RADICAVA 2 No known drug interactions based on in vitro drug interaction studies 1 RADICAVA ORS Was Generally Well Tolerated 1,3 The safety profile of RADICAVA ORS was demonstrated in a 6-month, phase 3, open-label clinical trial in 185 patients
Your provider builds the protocol around what we are actually trying to move clinically, not a default dose
Additionally, newer tests such as MicroGenDX labs as well as others, may provide some benefit in identifying pathogens that typical labs do not pick up because of newer testing methods, also offering information on antibiotic resistance which may be a valuable tool if you do in fact suffer from recurring infections